Why Moderna Stock Skyrocketed Today
13 Articles
13 Articles
The two US pharmaceutical companies Moderna and Merck may have achieved a breakthrough in a potential vaccine against black skin cancer, which is well received by investors and analysts.
For those who thought the chip sector or cryptocurrencies could experience major price surges, buckle up for biotech: the share prices of pharmaceutical companies Merck and Moderna (in…
An experimental vaccine developed by Moderna and Merck offers new hope in oncology after demonstrating that it can prevent relapse in patients with high-risk melanoma. Administered in combination with Keytruda — an immunotherapy already widely used — innovative treatment brings a new therapeutic approach for people with skin cancer.
Coverage Details
Bias Distribution
- 43% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
